Cargando…

Tauroursodeoxycholic Acid Protects Retinal and Visual Function in a Mouse Model of Type 1 Diabetes

Purpose: Previous studies demonstrated that systemic treatment with tauroursodeoxycholic acid (TUDCA) is protective in in vivo mouse models of retinal degeneration and in culture models of hyperglycemia. This study tested the hypothesis that TUDCA will preserve visual and retinal function in a mouse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fu, Jieming, Aung, Moe H., Prunty, Megan C., Hanif, Adam M., Hutson, Lauren M., Boatright, Jeffrey H., Pardue, Machelle T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8400977/ https://www.ncbi.nlm.nih.gov/pubmed/34452115 http://dx.doi.org/10.3390/pharmaceutics13081154

Ejemplares similares

Daily visual stimulation in the critical period enhances multiple aspects of vision through BDNF-mediated pathways in the mouse retina
por: Mui, Amanda M., et al.
Publicado: (2018)

Review: The bile acids urso- and tauroursodeoxycholic acid as neuroprotective therapies in retinal disease
por: Daruich, Alejandra, et al.
Publicado: (2019)

Low-Intensity Exercise in Mice Is Sufficient to Protect Retinal Function During Light-Induced Retinal Degeneration
por: Mees, Lukas M., et al.
Publicado: (2019)

Wheel running exercise protects against retinal degeneration in the I307N rhodopsin mouse model of inducible autosomal dominant retinitis pigmentosa
por: Zhang, Xian, et al.
Publicado: (2019)

Comparative Analysis of Urso- and Tauroursodeoxycholic Acid Neuroprotective Effects on Retinal Degeneration Models
por: Daruich, Alejandra, et al.
Publicado: (2022)

Bile acids in treatment of ocular disease
por: Boatright, Jeffrey H., et al.
Publicado: (2009)

Comparison of refractive development and retinal dopamine in OFF pathway mutant and C57BL/6J wild-type mice
por: Chakraborty, Ranjay, et al.
Publicado: (2014)

Dopamine Deficiency Mediates Early Rod-Driven Inner Retinal Dysfunction in Diabetic Mice
por: Kim, Moon K., et al.
Publicado: (2018)

Tauroursodeoxycholic Acid (TUDCA) Protects Photoreceptors from Cell Death after Experimental Retinal Detachment
por: Mantopoulos, Dimosthenis, et al.
Publicado: (2011)

Xanthohumol Protects Morphology and Function in a Mouse Model of Retinal Degeneration
por: Henneman, Nathaniel F., et al.
Publicado: (2018)

Tauroursodeoxycholic Acid Protects Retinal Pigment Epithelial Cells from Oxidative Injury and Endoplasmic Reticulum Stress In Vitro
por: Alhasani, Reem Hasaballah, et al.
Publicado: (2020)

Faster emergence behavior from ketamine/xylazine anesthesia with atipamezole versus yohimbine
por: Mees, Lukas, et al.
Publicado: (2018)

Subretinal electrical stimulation preserves inner retinal function in RCS rat retina
por: Ciavatta, Vincent T., et al.
Publicado: (2013)

Short-Wavelength (Violet) Light Protects Mice From Myopia Through Cone Signaling
por: Strickland, Ryan, et al.
Publicado: (2020)

Mechanisms of tauroursodeoxycholate-mediated inhibition of apoptosis
por: Sommerfeld, Annika, et al.
Publicado: (2014)

Assessment of Visual and Retinal Function Following In Vivo Genipin-Induced Scleral Crosslinking
por: Hannon, Bailey G., et al.
Publicado: (2020)

Systemic Treatment With Nicotinamide Riboside Is Protective in a Mouse Model of Light-Induced Retinal Degeneration
por: Zhang, Xian, et al.
Publicado: (2020)

Systemic Treatment with Nicotinamide Riboside Is Protective in Two Mouse Models of Retinal Ganglion Cell Damage
por: Zhang, Xian, et al.
Publicado: (2021)

Therapeutic Potential of Tauroursodeoxycholic Acid for the Treatment of Osteoporosis
por: Ahn, Tae-Keun, et al.
Publicado: (2020)

Light Environment Influences Developmental Programming of the Metabolic and Visual Systems in Mice
por: Clarkson-Townsend, Danielle A., et al.
Publicado: (2021)

Neuroprotective Effect of Tauroursodeoxycholic Acid on N-Methyl-D-Aspartate-Induced Retinal Ganglion Cell Degeneration
por: Gómez-Vicente, Violeta, et al.
Publicado: (2015)

Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis
por: Elia, A. E., et al.
Publicado: (2015)

Physical Activity and Quality of Life in Retinitis Pigmentosa
por: Levinson, Joshua D., et al.
Publicado: (2017)

Tauroursodeoxycholic Acid Inhibits Clostridioides difficile Toxin-Induced Apoptosis
por: Pike, Colleen M., et al.
Publicado: (2022)

Tauroursodeoxycholic Acid Attenuates Renal Tubular Injury in a Mouse Model of Type 2 Diabetes
por: Zhang, Jing, et al.
Publicado: (2016)

Retinal degeneration increases susceptibility to myopia in mice
por: Park, Hanna, et al.
Publicado: (2013)

Initiation of L-DOPA Treatment After Detection of Diabetes-Induced Retinal Dysfunction Reverses Retinopathy and Provides Neuroprotection in Rats
por: Chesler, Kyle, et al.
Publicado: (2021)

Tauroursodeoxycholic acid prevents Burkholderia pseudomallei-induced endoplasmic reticulum stress and is protective during melioidosis in mice
por: Yuan, Siqi, et al.
Publicado: (2021)

Preparation and toxicity evaluation of a novel nattokinase-tauroursodeoxycholate complex
por: Feng, Rui, et al.
Publicado: (2018)

Tauroursodeoxycholic acid: a potential therapeutic tool in neurodegenerative diseases
por: Khalaf, Kareem, et al.
Publicado: (2022)

Effect of Tauroursodeoxycholic Acid on Inflammation after Ocular Alkali Burn
por: Huang, Yanqiao, et al.
Publicado: (2022)

Altered Refractive Development in Mice With Reduced Levels of Retinal Dopamine
por: Bergen, Michael A., et al.
Publicado: (2016)

Ambient Light Regulates Retinal Dopamine Signaling and Myopia Susceptibility
por: Landis, Erica G., et al.
Publicado: (2021)

Controlled delivery of tauroursodeoxycholic acid from biodegradable microspheres slows retinal degeneration and vision loss in P23H rats
por: Fernández-Sánchez, Laura, et al.
Publicado: (2017)

Tauroursodeoxycholic acid in patients with amyotrophic lateral sclerosis: The TUDCA-ALS trial protocol
por: Albanese, Alberto, et al.
Publicado: (2022)

Tauroursodeoxycholic acid attenuates endoplasmic reticulum stress and protects the liver from chronic intermittent hypoxia induced injury
por: Hou, Yanpeng, et al.
Publicado: (2017)

Tauroursodeoxycholic acid reduces glial cell activation in an animal model of acute neuroinflammation
por: Yanguas-Casás, Natalia, et al.
Publicado: (2014)

IRBP deficiency permits precocious ocular development and myopia
por: Markand, Shanu, et al.
Publicado: (2016)

The Unexpected Uses of Urso- and Tauroursodeoxycholic Acid in the Treatment of Non-liver Diseases
por: Vang, Sheila, et al.
Publicado: (2014)

Tauroursodeoxycholic acid: more than just a neuroprotective bile conjugate
por: Romero-Ramírez, Lorenzo, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1v1fbsp6dkrjlr5j9hoqr2a2r9